Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome

Table 2

The AHA/NHLBI 2005 criteria for metabolic syndrome [19] and the pass criteria by patients in the study group.

Patient	Sex	HDL (mg/dl)	Triglyceride (mg/dl)	Waist circumference (cm)	Hypertension or pharmacologic therapy for hypertension	Diabetes mellitus or receiving pharmacologic therapy for elevated fasting glucose levels	Hypolipidemic therapy	Number of metabolic syndrome criteria met
1	F	27.5	329.9	116	Y	Y	Y	5
2	F	53	152	120	Y	Y	N	4
3	F	52.7	281.7	118	Y	Y	N	4
4	F	45	142	112	Y	N	Y	4
5	F	59.7	257	106	Y	N	Y	4
6	F	67	119	111	Y	N	Y	3
7	F	56.3	153.2	92	Y	N	Y	4
8	F	63.2	140.8	114	Y	Y	Y	4
9	F	60	170	124	Y	N	N	3
10	F	44	211	106	Y	Y	N	5
11	M	85.8	129	103	Y	N	Y	3
12	F	53.5	139	90	Y	Y	Y	4
13	F	36	315	90	N	N	Y	4
14	F	41.9	144	111	Y	Y	N	5
15	F	34	442	116	Y	Y	N	5
16	F	46.7	134.3	106	Y	Y	Y	5

The AHA and NHLBI require at least three of the following criteria for the diagnosis of the metabolic syndrome: (i) waist circumference of at least 40 inches (102 cm) in men or 35 inches (89 cm) in women, measured at the top of the iliac crest at the end of a normal expiration; (ii) triglyceride level of at least 150 mg per dl (1.70 mmol per l) or receiving pharmacologic therapy for elevated triglyceride levels; (iii) HDL cholesterol level of less than 40 mg per dl (1.05 mmol per L) in men or less than 50 mg per dl (1.30 mmol per L) in women or receiving pharmacologic therapy for reduced HDL cholesterol levels; (iv) systolic blood pressure of at least 130 mmHg or diastolic blood pressure of at least 85 mmHg or receiving pharmacologic therapy for hypertension; (v) fasting glucose level of at least 100 mg per dl (5.6 mmol per L) or receiving pharmacologic therapy for elevated fasting glucose levels.